{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:16:44Z","timestamp":1780046204275,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Waugh Family Foundation MS Society of Canada Operating Grant","award":["EGID 2639"],"award-info":[{"award-number":["EGID 2639"]}]},{"name":"Waugh Family Foundation MS Society of Canada Operating Grant","award":["EGID 2639"],"award-info":[{"award-number":["EGID 2639"]}]},{"name":"Waugh Family Foundation MS Society of Canada Operating Grant","award":["EGID 2639"],"award-info":[{"award-number":["EGID 2639"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["THC-135234"],"award-info":[{"award-number":["THC-135234"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["THC-135234"],"award-info":[{"award-number":["THC-135234"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["THC-135234"],"award-info":[{"award-number":["THC-135234"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007658","name":"Crohn\u2019s and Colitis Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Waugh Family Chair in Multiple Sclerosis"},{"name":"Bingham Chair in Gastroenterology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Reports of cognitive impairment in inflammatory bowel disease (IBD) have been mixed. IBD and cardiovascular disease are often co-morbid, yet it remains unknown whether vascular comorbidity confers a risk for decreased cognitive functioning, as observed in other populations. Participants with IBD were recruited from a longitudinal study of immune-mediated disease. Participants were administered a standardized neuropsychological test protocol, evaluating information processing speed, verbal learning and memory, visual learning and memory, and verbal fluency\/executive function. Cognitive test scores were standardized using local regression-based norms, adjusting for age, sex, and education. Vascular risk was calculated using a modified Framingham Risk Score (FRS). We tested the association between FRS and cognitive test scores using a quantile regression model, adjusting for IBD type. Of 84 IBD participants, 54 had ulcerative colitis and 30 had Crohn\u2019s disease; mean (SD) age was 53.36 (13.95) years, and a high proportion were females (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200958). As the risk score (FRS) increased, participants demonstrated lower performance in information processing speed (\u03b2\u2009=\u2009\u2212\u20090.12; 95% CI \u2212\u20090.24, \u2212\u20090.006) and verbal learning (\u03b2\u2009=\u2009\u2212\u20090.14; 95% CI \u2212\u20090.28, \u2212\u20090.01) at the 50\n                    <jats:sup>th<\/jats:sup>\n                    percentile. After adjusting for IBD type and disease activity, higher FRS remained associated with lower information processing speed (\u03b2\u2009=\u2009\u2212\u20090.14; 95% CI \u2212\u20090.27, \u2212\u20090.065). Vascular comorbidity is associated with lower cognitive functioning in persons with IBD, particularly in the area of information processing speed. These findings suggest that prevention, identification, and treatment of vascular comorbidity in IBD may play a critical role for improving functional outcomes in IBD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-31160-3","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T10:04:23Z","timestamp":1678874663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Ronak","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase R.","family":"Figley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kornelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Mazerolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Nasir","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Comorbidity and Cognition in Multiple Sclerosis (CCOMS) Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kornelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Mazerolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa D.","family":"Figley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Helmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"issue":"4","key":"31160_CR1","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein, C. N. et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study. Am. J. Gastroenterol. 96(4), 1116\u20131122 (2001).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"31160_CR2","first-page":"58","volume":"2","author":"GG Kaplan","year":"2018","unstructured":"Kaplan, G. G. et al. The impact of inflammatory bowel disease in Canada 2018: Epidemiology. J. Can. Assoc. Gastroenterol. 2(1), 58 (2018).","journal-title":"J. Can. Assoc. Gastroenterol."},{"issue":"1","key":"31160_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab, S. et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol. Hepatol. 5(1), 17\u201330 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"31160_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2020","unstructured":"Morais, L. H., Schreiber, H. L. & Mazmanian, S. K. The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. 19(4), 241\u2013255 (2020).","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"31160_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/nmo.12219","volume":"25","author":"JW Berrill","year":"2013","unstructured":"Berrill, J. W. et al. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol. Motility 25(11), 58 (2013).","journal-title":"Neurogastroenterol. Motility"},{"issue":"1","key":"31160_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","volume":"144","author":"BL Bonaz","year":"2013","unstructured":"Bonaz, B. L. & Bernstein, C. N. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 144(1), 36\u201349 (2013).","journal-title":"Gastroenterology."},{"key":"31160_CR7","first-page":"11","volume":"5","author":"D Kempuraj","year":"2017","unstructured":"Kempuraj, D. et al. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front. Cell. Neurosci. 5, 11 (2017).","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"31160_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psym.2020.10.002","volume":"62","author":"CWP Hopkins","year":"2021","unstructured":"Hopkins, C. W. P. et al. Cognitive impairment in adult inflammatory bowel disease: A systematic review and meta-analysis. J. Acad. Consultation-Liaison Psychiat. 62(4), 387\u2013403 (2021).","journal-title":"J. Acad. Consultation-Liaison Psychiat."},{"issue":"2","key":"31160_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1207\/S15324826AN1002_05","volume":"10","author":"EA Attree","year":"2003","unstructured":"Attree, E. A. et al. Cognitive function in people with chronic illness: Inflammatory bowel disease and irritable bowel syndrome. Appl. Neuropsychol. 10(2), 96\u2013104 (2003).","journal-title":"Appl. Neuropsychol."},{"issue":"6","key":"31160_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ibd.20837","volume":"15","author":"CP Dancey","year":"2009","unstructured":"Dancey, C. P. et al. Words fail me: The verbal IQ deficit in inflammatory bowel disease and irritable bowel syndrome. Inflamm. Bowel Dis. 15(6), 852\u2013857 (2009).","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"31160_CR11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3748\/wjg.v19.i10.1611","volume":"19","author":"AE Castaneda","year":"2013","unstructured":"Castaneda, A. E. Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease. World J. Gastroenterol. 19(10), 1611 (2013).","journal-title":"World J. Gastroenterol."},{"key":"31160_CR12","first-page":"89","volume":"5","author":"CN Bernstein","year":"2021","unstructured":"Bernstein, C. N. et al. Comorbidity before and after a diagnosis of inflammatory bowel disease. Aliment. Pharmacol. Therap. 5, 89 (2021).","journal-title":"Aliment. Pharmacol. Therap."},{"issue":"3","key":"31160_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1389450116666150202161500","volume":"16","author":"R Schicho","year":"2015","unstructured":"Schicho, R., Marsche, G. & Storr, M. Cardiovascular complications in inflammatory bowel disease. Curr. Drug Targets 16(3), 181\u2013188 (2015).","journal-title":"Curr. Drug Targets"},{"key":"31160_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CEG.S243478","volume":"13","author":"RB Biondi","year":"2020","unstructured":"Biondi, R. B. et al. Cardiovascular risk in individuals with inflammatory bowel disease. Clin. Exp. Gastroenterol. 13, 107\u2013113 (2020).","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"8","key":"31160_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2468-1253(19)30173-6","volume":"4","author":"M Argollo","year":"2019","unstructured":"Argollo, M. et al. Comorbidities in inflammatory bowel disease: A call for action. Lancet Gastroenterol. Hepatol. 4(8), 643\u2013654 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"31160_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnp.12039","volume":"9","author":"BP Vasquez","year":"2015","unstructured":"Vasquez, B. P. & Zakzanis, K. K. The neuropsychological profile of vascular cognitive impairment not demented: A meta-analysis. J. Neuropsychol. 9(1), 109\u2013136 (2015).","journal-title":"J. Neuropsychol."},{"issue":"6","key":"31160_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino, R. B. et al. General Cardiovascular Risk Profile for use in primary care. Circulation 117(6), 743\u2013753 (2008).","journal-title":"Circulation"},{"key":"31160_CR18","first-page":"6","volume":"9","author":"JM Rondina","year":"2014","unstructured":"Rondina, J. M. et al. Framingham coronary heart disease risk score can be predicted from structural brain images in elderly subjects. Front. Aging Neurosci. 9, 6 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"31160_CR19","doi-asserted-by":"publisher","first-page":"103088","DOI":"10.1016\/j.msard.2021.103088","volume":"54","author":"RA Marrie","year":"2021","unstructured":"Marrie, R. A. et al. Higher Framingham risk scores are associated with greater loss of brain volume over time in multiple sclerosis. Multiple Sclerosis Relat. Disord. 54, 103088 (2021).","journal-title":"Multiple Sclerosis Relat. Disord."},{"key":"31160_CR20","doi-asserted-by":"crossref","unstructured":"Restrepo C, Werden E, Singleton R, et al. Comparison of brain atrophy and cognitive performance in individuals with low and high cardiovascular risk: Data from the Diabetes and Dementia (D2) Study. Alzheimer\u2019s and Dementia 2020.","DOI":"10.1002\/alz.039593"},{"issue":"1","key":"31160_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2196\/resprot.8794","volume":"7","author":"RA Marrie","year":"2018","unstructured":"Marrie, R. A. et al. Effects of psychiatric comorbidity in immune-mediated inflammatory disease: Protocol for a prospective study. JMIR Res. Protocols 7(1), 58 (2018).","journal-title":"JMIR Res. Protocols"},{"issue":"11","key":"31160_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","volume":"61","author":"BF Grant","year":"2004","unstructured":"Grant, B. F. et al. Nicotine dependence and psychiatric disorders in the United States. Arch. Gen. Psychiatry 61(11), 1107 (2004).","journal-title":"Arch. Gen. Psychiatry"},{"key":"31160_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg, M. S. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19, 5\u201336 (2005).","journal-title":"Can. J. Gastroenterol."},{"key":"31160_CR24","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","volume":"20","author":"JF Lin","year":"2014","unstructured":"Lin, J. F. et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis 20, 1407\u20131415 (2014).","journal-title":"Inflamm Bowel Dis"},{"key":"31160_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000311013","volume":"35","author":"M Horton","year":"2010","unstructured":"Horton, M., Rudick, R. A., Hara-Cleaver, C. & Marrie, R. A. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 35, 83\u201390 (2010).","journal-title":"Neuroepidemiology"},{"key":"31160_CR26","unstructured":"Smith A. Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services, 1982."},{"key":"31160_CR27","volume-title":"California Verbal Learning Test, second edition, adult version: Manual","author":"DC Delis","year":"2000","unstructured":"Delis, D. C., Kramer, J. H., Kaplan, E. & Ober, B. A. California Verbal Learning Test, second edition, adult version: Manual (Psychological Corporation, 2000)."},{"key":"31160_CR28","unstructured":"Benedict RHB, & Brandt J. Hopkins Verbal Learning Test-Revised \/ Brief Visuospatial Memory Test-Revised: Professional Manual Supplement. Odessa: Psychological Assessment Resources, 1997."},{"key":"31160_CR29","volume-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"E Strauss","year":"2006","unstructured":"Strauss, E., Sherman, E. M. S. & Spreen, O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 3rd edn. (Oxford University Press, 2006).","edition":"3"},{"issue":"5","key":"31160_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.bbadis.2008.09.004","volume":"1792","author":"E van den Berg","year":"2009","unstructured":"van den Berg, E. et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochimica Et Biophysica Acta Mol. Basis Dis. 1792(5), 470\u2013481 (2009).","journal-title":"Biochimica Et Biophysica Acta Mol. Basis Dis."},{"issue":"23","key":"31160_CR31","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1212\/WNL.0000000000001655","volume":"84","author":"G Weinstein","year":"2015","unstructured":"Weinstein, G. et al. Glucose indices are associated with cognitive and structural brain measures in Young Adults. Neurology 84(23), 2329\u20132337 (2015).","journal-title":"Neurology"},{"key":"31160_CR32","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2011.\u00a0Diabetes care 2011;\u00a034 Suppl 1(Suppl 1):S11\u2013S61.","DOI":"10.2337\/dc11-S011"},{"issue":"6","key":"31160_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67(6), 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"31160_CR34","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/ibd\/izy068","volume":"24","author":"CN Bernstein","year":"2018","unstructured":"Bernstein, C. N. et al. The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease. Inflamm. Bowel Dis. 24(9), 1867\u20131875 (2018).","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"31160_CR35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/ibd\/izaa349","volume":"27","author":"RA Marrie","year":"2021","unstructured":"Marrie, R. A. et al. The relationship between symptoms of depression and anxiety and disease activity in IBD over time. Inflamm. Bowel Dis. 27(8), 1285\u20131293 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"31160_CR36","first-page":"11","volume":"9","author":"RA Marrie","year":"2021","unstructured":"Marrie, R. A. et al. Performance of regression-based norms for cognitive functioning of persons with multiple sclerosis in an independent sample. Front. Neurol. 9, 11 (2021).","journal-title":"Front. Neurol."},{"key":"31160_CR37","volume-title":"Wechsler Test of Adult Reading: WTAR","author":"D Wechsler","year":"2001","unstructured":"Wechsler, D. Wechsler Test of Adult Reading: WTAR (Psychological Corporation, 2001)."},{"issue":"4","key":"31160_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1257\/jep.15.4.143","volume":"15","author":"R Koenker","year":"2001","unstructured":"Koenker, R. & Hallock, K. F. Quantile regression. J. Econ. Pers. 15(4), 143\u2013156 (2001).","journal-title":"J. Econ. Pers."},{"issue":"7","key":"31160_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/arclin\/act046","volume":"28","author":"KA Gifford","year":"2013","unstructured":"Gifford, K. A. et al. Blood pressure and cognition among older adults: A meta-analysis. Arch. Clin. Neuropsychol. 28(7), 649\u2013664 (2013).","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"9","key":"31160_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11892-016-0775-x","volume":"16","author":"LA Zilliox","year":"2016","unstructured":"Zilliox, L. A. et al. Diabetes and cognitive impairment. Curr. Diabetes Rep. 16(9), 49 (2016).","journal-title":"Curr. Diabetes Rep."},{"issue":"3","key":"31160_CR41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1017\/S1355617713001483","volume":"20","author":"P Palta","year":"2014","unstructured":"Palta, P. et al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: A meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J. Int. Neuropsychol. Soc. 20(3), 278\u2013291 (2014).","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"1","key":"31160_CR42","doi-asserted-by":"publisher","first-page":"205521731882213","DOI":"10.1177\/2055217318822134","volume":"5","author":"A Kavaliunas","year":"2019","unstructured":"Kavaliunas, A. et al. Cognitive function predicts work disability among multiple sclerosis patients. Multiple Sclerosis J. 5(1), 2055217318822134. https:\/\/doi.org\/10.1177\/2055217318822134 (2019).","journal-title":"Multiple Sclerosis J."},{"issue":"9","key":"31160_CR43","doi-asserted-by":"publisher","first-page":"e006044","DOI":"10.1136\/bmjopen-2014-006044","volume":"4","author":"KJL Bell","year":"2014","unstructured":"Bell, K. J. L. et al. Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study data. BMJ Open. 4(9), e006044. https:\/\/doi.org\/10.1136\/bmjopen-2014-006044 (2014).","journal-title":"BMJ Open."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31160-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T10:08:15Z","timestamp":1678874895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31160-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2135231\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Bernstein is supported in part by the Bingham Chair in Gastroenterology. Dr. Bernstein has consulted to Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Roche Canada, Sandoz Canada, Takeda Canada, and has received unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, and Takeda Canada. He has consulted to Takeda and Mylan Pharmaceuticals. He has been on the speaker\u2019s bureau of Abbvie Canada, Janssen Canada, Medtronic Canada and Takeda Canada. He has received a research grant from Abbvie Canada and contract grants from Abbvie, Janssen, Pfizer, Roche, Boeringher Ingelheim. Dr Graff has consulted to Roche Canada. All other authors do not possess any competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4317"}}